title: [ROS1 fusion proteins, targets of foretinib].
authors.forename: Jean
authors.initials: J
authors.lastname: Bénard
mesh_terms: D000077548:Anaplastic Lymphoma Kinase; D000813:Anilides / Q000627:therapeutic use*; D000077547:Crizotinib; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors* / Q000235:genetics; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors*; D011720:Pyrazoles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use*; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics
chemical_list: D000813:Anilides; C544831:GSK 1363089; D015514:Oncogene Proteins, Fusion; D047428:Protein Kinase Inhibitors; D011518:Proto-Oncogene Proteins; D011720:Pyrazoles; D011725:Pyridines; D011804:Quinolines; D000077547:Crizotinib; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; C062333:ROS1 protein, human; D020794:Receptor Protein-Tyrosine Kinases